Skip to main content

Pinnacle-Hip Lawsuit - J&J Agrees To Pay $1 Billion

Pinnacle-Hip Lawsuit - J&J Agrees To Pay $1 Billion

Pinnacle-Hip Lawsuit - J&J Agrees To Pay $1 Billion

Introduction

Johnson & Johnson has agreed to pay $1 billion to resolve claims involving personal injury linked to the usage of a metal-on-metal version of DePuy Orthopaedics.

There are around 10,000 Depuy Pinnacle hip lawsuits that are currently pending in multidistrict litigation centralized in U.S. District Court, Northern District of Texas. As per the recent agreement with Texas juries, more than 95 percent of the 6,000 cases have been resolved. J&J agreed to pay $120 million last February to settle 46 state attorneys generals’ allegations linked to ambiguous claims about the hips’ durability. In November 2013, the company had announced a $2.5 billion settlement to resolve 93,000 claims filed in connection with the DePuy ASR hip recall. The sales of metal Ultamet liner ended in May 2013, after regulatory restrictions by U.S. Food & Drug Administration. However,  the sales of Pinnacle hips made from other materials were not affected.

The Pinnacle lawsuits are centralized under MDL 3:11-MD-02244, In Re: DePuy Orthopaedics, Inc., Pinnacle Hip Implant Products Liability Litigation, U.S District Court, Northern District of Texas (Dallas). Similar lawsuits are filed against other hip device manufacturers in the U.S. involving defendants Zimmer, Stryker, Biomet, Wright, and Smith & Nephew.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!